Banyan Capital Management Inc. Has $7.11 Million Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Banyan Capital Management Inc. trimmed its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 19.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 102,722 shares of the company's stock after selling 24,712 shares during the quarter. Henry Schein makes up approximately 4.3% of Banyan Capital Management Inc.'s portfolio, making the stock its 12th largest position. Banyan Capital Management Inc. owned approximately 0.08% of Henry Schein worth $7,108,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Cromwell Holdings LLC boosted its holdings in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock worth $26,000 after buying an additional 170 shares during the period. Versant Capital Management Inc boosted its holdings in shares of Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $32,000 after purchasing an additional 335 shares during the period. Venturi Wealth Management LLC boosted its holdings in shares of Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after purchasing an additional 569 shares during the period. Quent Capital LLC boosted its holdings in shares of Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after purchasing an additional 323 shares during the period. Finally, City State Bank acquired a new stake in shares of Henry Schein during the fourth quarter worth approximately $55,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Stock Performance

Shares of Henry Schein stock traded down $0.81 on Friday, reaching $77.24. The stock had a trading volume of 3,295,278 shares, compared to its average volume of 1,668,216. The business's 50-day moving average price is $74.14 and its two-hundred day moving average price is $72.21. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The stock has a market cap of $9.63 billion, a P/E ratio of 31.79, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91.

Analyst Upgrades and Downgrades

HSIC has been the subject of several research reports. Mizuho initiated coverage on shares of Henry Schein in a report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price target for the company. Wells Fargo & Company initiated coverage on shares of Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target for the company. Jefferies Financial Group raised their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and lifted their target price for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Finally, Barrington Research lifted their target price on shares of Henry Schein from $82.00 to $90.00 and gave the company an "outperform" rating in a research note on Thursday, January 30th. Eight investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $80.09.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.